Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06310616 · ClinicalTrials.gov registry record · Phase 1
A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants
A Phase 1 study, sponsored by ViiV Healthcare.
- Completed
- Registry status
- Phase 1
- Development phase
- 26
- Enrollment target
NCT06310616 is a Phase 1 study that has completed, run by ViiV Healthcare. The registered enrollment target is 26 participants.
The verdict
NCT06310616, a Phase 1 study, has completed, sponsored by ViiV Healthcare.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 26 participants
- Enrollment target
Study Summary
This study aims to assess any impact of VH4524184 on the pharmacokinetic (PK) profile of an ethinyl estradiol (EE) and norethindrone acetate (NEA) containing oral contraceptive (OC) administered to healthy adult female participants.
Interventions
- DRUG VH4524184
- DRUG Loestrin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2024-03-06 |
| Est. Completion | 2024-08-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06310616
The ClinicalTrials.gov registry entry for NCT06310616 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which VH4524184 is the first listed.
NCT06310616 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06310616 about?
NCT06310616 is a clinical study titled "A Study to Investigate the Potential Drug-Drug Interaction Between VH4524184 and Oral Contraceptive (Loestrin) in Healthy Adult Female Participants". This study aims to assess any impact of VH4524184 on the pharmacokinetic (PK) profile of an ethinyl estradiol (EE) and norethindrone acetate (NEA) containing oral contraceptive (OC) administered to healthy adult female participants.
What is the current status of trial NCT06310616?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 26 participants. The study started on 2024-03-06. Estimated completion is 2024-08-15.
What interventions are being tested in trial NCT06310616?
The interventions under investigation include: VH4524184 (DRUG), Loestrin (DRUG).
Who is sponsoring clinical trial NCT06310616?
This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.